McKinley Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
McKinley Capital Management's RGEN Position: Q2 2023 in Review
McKinley Capital Management sold out of Repligen (RGEN) in Q2 2023, closing a stake of 13,590 shares — an estimated $2.29M sold.
McKinley Capital Management first reported a position in RGEN in Q3 2013 and held it in 25 quarters. The position peaked at $8.41M in Q2 2015. 447 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.
- McKinley Capital Management reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
- McKinley Capital Management sold 13,590 Repligen shares in Q2 2023, an estimated $2.29M.
- McKinley Capital Management first reported a position in Repligen in Q3 2013 and held it in 25 quarters.
- McKinley Capital Management's Repligen position peaked at $8.41M in Q2 2015.
- 447 funds tracked by Wall St. Rank held Repligen as of Q2 2023.
Based on McKinley Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.